奥精医疗：多位董高拟减持不超0.18%公司股份

Core Viewpoint - The announcement from AoJing Medical indicates that several executives plan to reduce their shareholdings due to personal financial needs, which may impact investor sentiment and stock performance [1] Summary by Relevant Sections Executive Shareholding Reduction - CEO Qiu Zhiye intends to reduce his holdings by no more than 95,000 shares, accounting for up to 0.07% of total shares [1] - CFO Wang Ling plans to sell up to 70,312 shares, representing no more than 0.05% [1] - Vice President Song Tianxi aims to decrease his stake by up to 50,000 shares, which is about 0.04% [1] - Vice President Tian Guofeng will reduce his holdings by no more than 37,500 shares, equivalent to approximately 0.03% [1] Timeline for Share Reduction - The reduction period is set from December 3, 2025, to March 3, 2026 [1] Source of Shares - All shares to be sold are derived from equity incentives received by the executives [1]